Fresenius SE & Co. (OTCMKTS:FSNUY) Posts Earnings Results

Fresenius SE & Co. (OTCMKTS:FSNUY) released its quarterly earnings data on Wednesday. The company reported $0.28 EPS for the quarter, Zacks reports. Fresenius SE & Co. had a return on equity of 10.38% and a net margin of 5.71%.The company had revenue of $6.94 billion during the quarter.

Fresenius SE & Co. Price Performance

Shares of FSNUY opened at $15.21 on Friday. The firm has a market cap of $34.27 billion, a P/E ratio of 24.14 and a beta of 0.75. The company has a debt-to-equity ratio of 0.49, a quick ratio of 0.99 and a current ratio of 1.26. Fresenius SE & Co. has a 52 week low of $9.78 and a 52 week high of $33.93. The firm’s 50-day simple moving average is $14.58 and its 200 day simple moving average is $14.40.

Analyst Upgrades and Downgrades

Several analysts have issued reports on FSNUY shares. Morgan Stanley reaffirmed an “overweight” rating on shares of Fresenius SE & Co. in a research report on Monday, December 15th. Citigroup restated a “buy” rating on shares of Fresenius SE & Co. in a research note on Tuesday, February 3rd. Three analysts have rated the stock with a Buy rating, According to data from MarketBeat.com, the stock presently has a consensus rating of “Buy”.

Fresenius SE & Co. Company Profile

Fresenius SE & Co KGaA is a global healthcare group headquartered in Bad Homburg vor der Höhe, Germany. Founded in 1912 by Eduard Fresenius, the company has grown into one of the world’s leading providers of products and services for dialysis, hospitals and outpatient medical care. Trading on major European exchanges and available over the counter in the U.S. as FSNUY, Fresenius SE & Co brings together a portfolio of specialized healthcare businesses under one corporate umbrella.

The company operates through four main business segments.